XML 59 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8

9. STOCK COMPENSATION (Tables)

9 Months Ended

Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Components of share-based compensation expenses relating to shares and options granted

		Three Months Ended				Three Months Ended				Nine Months Ended				Nine Months Ended
		December 31, 2013				December 31, 2012				December 31, 2013				December 31, 2012
Total share-based compensation expense		$	32,750			$	175,045			$	223,351			$	570,540
Total share-based compensation expense included in net loss		$	32,750			$	175,045			$	223,351			$	570,540
Basic and diluted loss per common share		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)

		Three Months Ended				Three Months Ended				Nine Months Ended				Nine Months Ended
		December 31, 2013				December 31, 2012				December 31, 2013				December 31, 2012
Vesting of stock options			32,750				77,421				156,993				258,468
Incremental fair value of option modifications			--				957				1,914				22,071
Vesting expense associated with CEO restricted stock grant			--				96,667				64,444				290,001
Total share-based compensation expense		$	32,750			$	175,045			$	223,351			$	570,540
Total share-based compensation expense included in net loss		$	32,750			$	175,045			$	223,351			$	570,540
Basic and diluted loss per common share		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)

Weighted average assumptions used to estimate the fair value information

Risk free interest rate	0.38% - 2.50%
Average expected life	3 years - 10 years
Expected volatility	94.6% - 102.7%
Expected dividends	None

Options outstanding

										Weighted
						Weighted				Average
						Average				Remaining
		Number of				Exercise				Contractual
		Shares				Price				Term in Years
Vested			21,012,455			$	0.28				3.63
Expected to vest			3,708,343			$	0.11				9.45
Total			24,720,798			$	0.26				4.50

Stock option activity

		Number of Options				Range of Exercise  Price		Weighted Average Exercise  Price
Stock options outstanding at March 31, 2013			21,095,798			$0.76 - $0.41		$0.28
Exercised			–			$--
Granted			3,625,000			$0.10 - 0.11		$0.10
Cancelled/Expired			–			--
Stock options outstanding at December 31, 2013			24,720,798			$0.076 - $0.41		$0.28
Stock options exercisable at December 31, 2013			21,012,455			$0.076 - $0.41		$0.26

X

- Definition

Components of share-based compensation expenses relating to shares and options granted

+ References

No definition available.

+ Details

Name:	aemd_ComponentsShareBasedCompensationExpensesRelatingToSharesAndOptionsGrantedTableTextBlock
Namespace Prefix:	aemd_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the following for fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position: the number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration